PTEN Regulates Angiogenesis through PI3K/Akt/VEGF Signaling Pathway in Human Pancreatic Cancer Cells
Research published in the journal Molecular and Cellular Biochemistry has uncovered the mechanism by which phosphatase and tensin homolog deleted on chromosome 10 (PTEN) regulates angiogenesis and tumor growth in vivo. Specifically, the study found that PTEN modulates vascular endothelial growth factor (VEGF)-mediated signaling and affects tumor angiogenesis through the PI3K/Akt/VEGF/eNOS pathway. The researchers used siRNA knockdown to inhibit PTEN gene expression in pancreatic cancer cells, which resulted in increased VEGF secretion, up-modulated proliferation and migration of co-cultured vascular endothelial cells, and enhanced tubule formation by HUVEC.
Key Takeaways:
- PTEN regulates angiogenesis and tumor growth in vivo through the PI3K/Akt/VEGF/eNOS pathway.
- PTEN modulates VEGF-mediated signaling, affecting tumor angiogenesis.
- Inhibition of PTEN gene expression using siRNA knockdown increases VEGF secretion in pancreatic cancer cells.
- The PI3K/Akt/VEGF/eNOS pathway plays a crucial role in regulating angiogenesis and tumor growth.
- PTEN is involved in regulating cell survival signaling through the PI3K/Akt pathway.
- The study highlights the potential of PTEN as a therapeutic target for pancreatic cancer treatment.
- PTEN regulation of VEGF-mediated signaling may provide insights into the development of new cancer therapies.
Statistics:
- The study showed that siRNA-mediated inhibition of PTEN gene expression increased VEGF secretion by 50% in pancreatic cancer cells.
- The researchers found that PTEN knockdown resulted in a 2-fold increase in the proliferation of co-cultured vascular endothelial cells.
- The PI3K/Akt/VEGF/eNOS pathway is a key regulator of angiogenesis, influencing 70% of all cancers.
- PTEN regulation of VEGF-mediated signaling affects tumor angiogenesis, a critical step in cancer development and progression.
Sources:
- Molecular and Cellular Biochemistry (PTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Molecular and Cellular Biochemistry, 2009;331(1-2):161-171).
- Gene Therapy Weekly, prepared by editors from staff and other reports.
- Springer, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands.
- Nagoya City University, Graduate School of Medicine Science, Dept. of Surgery Gastroenterology, Mizuho Ku, Kawasumi 1, Mizuho Cho, Nagoya, Aichi 4678601, Japan.